483 related articles for article (PubMed ID: 11916606)
1. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.
Seggewiss H; Faber L
Eur J Echocardiogr; 2000 Dec; 1(4):277-80. PubMed ID: 11916606
[TBL] [Abstract][Full Text] [Related]
2. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].
Seggewiss H; Faber L; Ziemssen P; Gleichmann U
Dtsch Med Wochenschr; 2001 Apr; 126(15):424-30. PubMed ID: 11347004
[TBL] [Abstract][Full Text] [Related]
3. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
[TBL] [Abstract][Full Text] [Related]
4. [Percutaneous transluminal ablation of the myocardial septum by embolization of the first branch of the anterior descending coronary artery using a small amount of absolute alcohol].
Miric M; Sagic D; Popovic Z; Zlatanovic M; Vlahovic A; Vidakovic R; Bojic M
Srp Arh Celok Lek; 2001; 129(7-8):199-202. PubMed ID: 11797450
[TBL] [Abstract][Full Text] [Related]
5. [Alcohol concentration in the coronary sinus after transarterial ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy].
Klein N; Mende M; Hagendorff A; Neugebauer A; Pfeiffer D
Dtsch Med Wochenschr; 2000 May; 125(19):579-83. PubMed ID: 11320715
[TBL] [Abstract][Full Text] [Related]
6. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
[TBL] [Abstract][Full Text] [Related]
7. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].
Krejcí J; Groch L; Meluzín J; Vykypel T; Halámek J; Vitovec J
Vnitr Lek; 2006 Apr; 52(4):313-20. PubMed ID: 16755987
[TBL] [Abstract][Full Text] [Related]
8. [Evolution of the surgical strategy in hypertrophic cardiomyopathy: case studies of eight patients].
Joudinaud T; Flecher E; Hvass U
Ann Cardiol Angeiol (Paris); 2008 Feb; 57(1):16-21. PubMed ID: 18054343
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous transluminal septal myocardial ablation in a child with hypertrophic obstructive cardiomyopathy and Noonan syndrome.
Singh H; Kalra R; Keshavamurthy GB; Singh M; Singh C
Congenit Heart Dis; 2008; 3(5):347-51. PubMed ID: 18837814
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
Alam M; Dokainish H; Lakkis NM
Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of alcohol septal ablation in patients with symptomatic concentric left ventricular hypertrophy and outflow tract obstruction.
Kovacic JC; Khanna D; Kaplish D; Karajgikar R; Sharma SK; Kini A
J Invasive Cardiol; 2010 Dec; 22(12):586-91. PubMed ID: 21127363
[TBL] [Abstract][Full Text] [Related]
12. [Percutaneous transluminal septal myocardial ablation in patients with obstructive septal hypertrophic myocardiopathy. Acute results and 3-year follow-up].
Llamas-Esperón GA; Loera Pinales A; Sandoval Navarrete S; Zamora Muciño A; Ramírez Robledo MA; Varela Ortiz S; Casas Juárez U; Fuantos Delgado Mde L; Albarrán Domínguez J; Muñoz Sandoval R; Sandoval Rodríguez E; Ruiz Esparza ME
Arch Cardiol Mex; 2009; 79(1):33-40. PubMed ID: 19545072
[TBL] [Abstract][Full Text] [Related]
13. Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
Zhang W; Li Z; Zhang M; Yuan L; Guan R; Hou A; Jin Y; Deng Z
Chin Med J (Engl); 2002 Sep; 115(9):1283-6. PubMed ID: 12411095
[TBL] [Abstract][Full Text] [Related]
14. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.
Veselka J
Med Sci Monit; 2007 Apr; 13(4):RA62-8. PubMed ID: 17392660
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets.
van der Lee C; ten Cate FJ; Geleijnse ML; Kofflard MJ; Pedone C; van Herwerden LA; Biagini E; Vletter WB; Serruys PW
Circulation; 2005 Jul; 112(4):482-8. PubMed ID: 16027255
[TBL] [Abstract][Full Text] [Related]
16. Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy.
Lawrenz T; Kuhn H
Z Kardiol; 2004 Jun; 93(6):493-9. PubMed ID: 15252744
[TBL] [Abstract][Full Text] [Related]
17. Long term exercise capacity in patients with hypertrophic cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
Malek LA; Chojnowska L; Klopotowski M; Maczynska R; Demkow M; Witkowski A; Kusmierczyk B; Piotrowicz E; Konka M; Dabrowski M; Ruzyllo W
Eur J Heart Fail; 2008 Nov; 10(11):1123-6. PubMed ID: 18840395
[TBL] [Abstract][Full Text] [Related]
18. New treatment strategies for hypertrophic obstructive cardiomyopathy: alcohol ablation of the septum: the new gold standard?
Hess OM; Sigwart U
J Am Coll Cardiol; 2004 Nov; 44(10):2054-5. PubMed ID: 15542291
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Outcome of Alcohol Septal Ablation With Confirmation by Nitroglycerin Test for Drug-Refractory Hypertrophic Obstructive Cardiomyopathy With Labile Left Ventricular Outflow Obstruction.
Kitamura M; Takayama M; Matsuda J; Kubota Y; Nakamura S; Takano H; Asai K; Shimizu W
Am J Cardiol; 2015 Sep; 116(6):945-51. PubMed ID: 26209114
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSound® technology to guide ablation.
Cooper RM; Shahzad A; Hasleton J; Digiovanni J; Hall MC; Todd DM; Modi S; Stables RH
Europace; 2016 Jan; 18(1):113-20. PubMed ID: 26541709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
